← Issue №19/ week of Nov 8, 2026/Endoscopy

Esophageal squamous papillomas.

From GI Signals issue №19: what this paper found, what it changes, and where it sits against the current standard of care, reviewed by Simon Mathews, MD.

Endoscopy retrospective · n=107 · Nov 2, 2026 · Diseases of the Esophagus · IF 2.5

Esophageal squamous papillomas.

New evidenceesophageal cancerepidemiology
Clinical takeawayTreat an isolated non-dysplastic squamous papilloma as a minor finding, but assess the wider mucosa and patient-level risk factors before dismissing it; the cohort's follow-up rate was low.
What it foundNo dysplasia found in 107 adults with esophageal squamous papilloma (ESP) at index endoscopy, with one synchronous squamous cell carcinoma and no metachronous dysplasia or carcinoma during follow-up.
ContextSupports ESP as a benign lesion in most cases, though the low follow-up rate limits the certainty of this conclusion. Provides a pragmatic approach to managing ESP, addressing prior inconsistent reports of malignant potential.
No standard claimed for this paper

Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.

Giovanis E … Zeki S · Diseases of the Esophagus : Official Journal of the International Society for Diseases of the Esophagus · IF 2.5 · PubMed ↗Permalink
← Read the whole of issue №19 Every paper GI Signals surfaces gets a page like this one. All issues